Social dysfunction is transdiagnostically associated with default mode network dysconnectivity in schizophrenia and Alzheimer's disease.


Journal

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
ISSN: 1814-1412
Titre abrégé: World J Biol Psychiatry
Pays: England
ID NLM: 101120023

Informations de publication

Date de publication:
Historique:
pubmed: 12 8 2021
medline: 2 11 2022
entrez: 11 8 2021
Statut: ppublish

Résumé

Social dysfunction is one of the most common signs of major neuropsychiatric disorders. The Default Mode Network (DMN) is crucially implicated in both psychopathology and social dysfunction, although the transdiagnostic properties of social dysfunction remains unknown. As part of the pan-European PRISM (Psychiatric Ratings using Intermediate Stratified Markers) project, we explored cross-disorder impact of social dysfunction on DMN connectivity. We studied DMN intrinsic functional connectivity in relation to social dysfunction by applying Independent Component Analysis and Dual Regression on resting-state fMRI data, among schizophrenia (SZ; Both SFS and LON were independently associated with diminished DMN connectional integrity within rostromedial prefrontal DMN subterritories ( These findings pinpoint DMN connectional alterations as putative transdiagnostic endophenotypes for social dysfunction and could aid personalised care initiatives grounded in social behaviour.

Identifiants

pubmed: 34378488
doi: 10.1080/15622975.2021.1966714
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

264-277

Auteurs

Ilja M J Saris (IMJ)

Department of Psychiatry, Amsterdam Neuroscience and Amsterdam Public Health Research Institute, Amsterdam UMC, VU Medical Centre and GGZ inGeest, Amsterdam, The Netherlands.

Moji Aghajani (M)

Department of Psychiatry, Amsterdam Neuroscience and Amsterdam Public Health Research Institute, Amsterdam UMC, VU Medical Centre and GGZ inGeest, Amsterdam, The Netherlands.
Institute of Education and Child Studies, Section Forensic Family and Youth Care, Leiden University, Leiden, The Netherlands.

Lianne M Reus (LM)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Pieter-Jelle Visser (PJ)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Yolande Pijnenburg (Y)

Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.

Nic J A van der Wee (NJA)

Department of Psychiatry, Leiden University Medical Centre, Leiden, The Netherlands.
Leiden Institute for Brain and Cognition, Leiden, The Netherlands.

Amy C Bilderbeck (AC)

P1vital Ltd, Wallingford, UK.

Andreea Raslescu (A)

P1vital Ltd, Wallingford, UK.

Asad Malik (A)

P1vital Ltd, Wallingford, UK.

Maarten Mennes (M)

SBGneuro Ltd, Oxford, UK.

Sanne Koops (S)

Department of Biomedical Sciences of Cells and Systems, Cognitive Neurosciences, University of Groningen, University Medical Center of Groningen, Groningen, The Netherlands.

Celso Arrango (C)

Hospital General Universitario Gregorio Marañón, CIBERSAM, IiSGM, Universidad Complutense, School of Medicine, Madrid, Spain.
Centre of Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.

Jose Luis Ayuso-Mateos (JL)

Centre of Biomedical Research in Mental Health (CIBERSAM), Madrid, Spain.
Department of Psychiatry, La Princesa University Hospital, Universidad Autonoma de Madrid, Marid, Spain.

Gerard R Dawson (GR)

P1vital Ltd, Wallingford, UK.

Hugh Marston (H)

Translational Neuroscience, Eli Lilly and Company, Windlesham, UK.
CNS Diseases Research, Boehringer Ingelheim GmbH and Company, Biberach, Germany.

Martien J Kas (MJ)

Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands.

Brenda W J H Penninx (BWJH)

Department of Psychiatry, Amsterdam Neuroscience and Amsterdam Public Health Research Institute, Amsterdam UMC, VU Medical Centre and GGZ inGeest, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH